future of glp-1 drugs Market Size to Hit USD 132.79 Bn by 2035 GLP-1 Drugs: Where We Are
Description
Ayoub, M., Faris, C., Juranovic, T., Chela, H
( 10.1111/1753-0407.12644) [DOI] [PubMed] [Google Scholar] Chai W Dong Z Wang N Wang W Tao L Cao W & Liu Z
Conversely, animals administered either GLP-1 or GLP-1MK-801 exhibited diminished locomotion compared with both MK-801-treated and vehicle-treated mice
Primary outcome The primary outcome, major adverse cardiovascular events (MACE), was reported in all 11 included studies, comprising of 91,490 participants with 4386 MACE events in the intervention group and 4884 MACE events in the placebo group
The experiment was performed on 3 separate occasions with similar results
